European Council’s conclusions on the European Innovation Agenda and research infrastructures
by Giuliana Miglierini The European socio-economic framework is undergoing a profound transformative moment, as a result of the…
How to approach drug substance supply in new product introduction (NPI) processes
by Giuliana Miglierini A key issue to be faced during pharmaceutical development refers to the supply of the…
ICMRA, two pilot programmes to optimise regulatory assessment and inspections
by Giuliana Miglierini New flexible modalities for the management of regulatory procedures are becoming progressively accepted even for…